D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LNW
2726
CALL
DELISTED
Light & Wonder
LNW
| $1.34M | ﹤0.01% |
50,200
+23,100
| +85% | +$595K |
|
|
CCXI
2727
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.34M | ﹤0.01% |
33,971
-19,446
| -36% | -$341K |
|
|
PPLI
2728
People Inc
PPLI
$3.13B
| $1.34M | ﹤0.01% |
30,103
-74,492
| -71% | -$3M |
|
2729
PUT
Ambarella
AMBA
$3.03B
| $1.34M | ﹤0.01% |
22,100
| – | – |
|
2730
CALL
Textron
TXT
$15.6B
| $1.34M | ﹤0.01% |
+30,000
| New | +$1.39M |
|
|
CRON
2731
Cronos Group
CRON
$1.06B
| $1.34M | ﹤0.01% |
174,308
-334,737
| -66% | -$2.56M |
|
|
JBGS
2732
JBG SMITH
JBGS
$837M
| $1.33M | ﹤0.01% |
33,391
+22,573
| +209% | +$893K |
|
2733
CALL
Conagra Brands
CAG
$7.38B
| $1.33M | ﹤0.01% |
38,800
+3,600
| +10% | +$104K |
|
2734
CALL
Generac Holdings
GNRC
$11.5B
| $1.33M | ﹤0.01% |
13,200
| – | – |
|
2735
PUT
Cooper-Standard Automotive
CPS
$526M
| $1.33M | ﹤0.01% |
40,000
+20,000
| +100% | +$648K |
|
2736
Deckers Outdoor
DECK
$14.2B
| $1.33M | ﹤0.01% |
47,100
-78,900
| -63% | -$2.09M |
|
2737
PUT
Zoetis
ZTS
$32.5B
| $1.32M | ﹤0.01% |
10,000
| – | – |
|
2738
Core Laboratories
CLB
$493M
| $1.32M | ﹤0.01% |
35,087
+23,537
| +204% | +$1.06M |
|
|
SCPL
2739
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $1.32M | ﹤0.01% |
107,350
+72,277
| +206% | +$768K |
|
|
SFIX
2740
Stitch Fix
SFIX
$563M
| $1.32M | ﹤0.01% |
+51,273
| New | +$1.19M |
|
2741
Weis Markets
WMK
$1.9B
| $1.31M | ﹤0.01% |
32,489
-2,881
| -8% | -$111K |
|
2742
PUT
Eli Lilly
LLY
$1.09T
| $1.31M | ﹤0.01% |
10,000
-50,000
| -83% | -$5.8M |
|
|
FPRX
2743
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.31M | ﹤0.01% |
286,096
+93,402
| +48% | +$370K |
|
2744
Nordson
NDSN
$16.9B
| $1.31M | ﹤0.01% |
8,037
+3,414
| +74% | +$539K |
|
2745
CALL
American States Water
AWR
$3.45B
| $1.31M | ﹤0.01% |
15,100
+7,400
| +96% | +$656K |
|
2746
PUT
Edgewell Personal Care
EPC
$1.3B
| $1.3M | ﹤0.01% |
42,000
-13,400
| -24% | -$432K |
|
|
CARO
2747
DELISTED
Carolina Financial Corp.
CARO
| $1.3M | ﹤0.01% |
30,074
+20,219
| +205% | +$797K |
|
|
RDS.B
2748
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.3M | ﹤0.01% |
21,659
-2,591
| -11% | -$153K |
|
2749
Zumiez
ZUMZ
$347M
| $1.29M | ﹤0.01% |
37,422
-67,757
| -64% | -$2.14M |
|
2750
CALL
Bruker
BRKR
$9.58B
| $1.29M | ﹤0.01% |
25,300
| – | – |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.